Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| December 31, 2023 | 88.43% |
| November 30, 2023 | 88.43% |
| October 31, 2023 | 88.43% |
| September 30, 2023 | 88.43% |
| August 31, 2023 | 88.43% |
| July 31, 2023 | 88.08% |
| June 30, 2023 | 84.96% |
| May 31, 2023 | 84.79% |
| April 30, 2023 | 84.79% |
| March 31, 2023 | 84.79% |
| February 28, 2023 | 83.70% |
| January 31, 2023 | 83.70% |
| December 31, 2022 | 83.70% |
| November 30, 2022 | 83.70% |
| October 31, 2022 | 83.70% |
| September 30, 2022 | 83.70% |
| August 31, 2022 | 83.70% |
| July 31, 2022 | 83.70% |
| June 30, 2022 | 90.04% |
| May 31, 2022 | 90.15% |
| April 30, 2022 | 93.08% |
| March 31, 2022 | 93.82% |
| February 28, 2022 | 94.13% |
| January 31, 2022 | 94.13% |
| December 31, 2021 | 94.13% |
| Date | Value |
|---|---|
| November 30, 2021 | 94.13% |
| October 31, 2021 | 94.13% |
| September 30, 2021 | 94.13% |
| August 31, 2021 | 94.13% |
| July 31, 2021 | 94.13% |
| June 30, 2021 | 94.13% |
| May 31, 2021 | 94.13% |
| April 30, 2021 | 94.13% |
| March 31, 2021 | 94.13% |
| February 28, 2021 | 94.13% |
| January 31, 2021 | 94.13% |
| December 31, 2020 | 94.13% |
| November 30, 2020 | 94.13% |
| October 31, 2020 | 94.13% |
| September 30, 2020 | 94.13% |
| August 31, 2020 | 94.13% |
| July 31, 2020 | 94.13% |
| June 30, 2020 | 94.13% |
| May 31, 2020 | 94.13% |
| April 30, 2020 | 94.13% |
| March 31, 2020 | 94.13% |
| February 29, 2020 | 94.13% |
| January 31, 2020 | 94.13% |
| December 31, 2019 | 94.13% |
| November 30, 2019 | 94.13% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
83.70%
Minimum
Jul 2022
94.13%
Maximum
Nov 2019
90.84%
Average
94.13%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Bristol-Myers Squibb Co | 47.67% |
| Karuna Therapeutics Inc (DELISTED) | -- |
| Puma Biotechnology Inc | 98.76% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |